Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP ...

At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their ...

The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, ...

Cam Ward's father, Calvin Ward, works at a nuclear power plant. His mother, Patrice, is a special education teacher. Cam Ward, of course, is the rookie starting quarterback for the Tennessee Titans, ...

Novo Nordisk’s board overhaul signals a decisive return to Foundation-led scientific and operational governance, raising strategic questions about whether the company can sustain U.S. growth and ...

Recent Gallup data shows a decline in U.S. obesity rates, likely linked to widespread use of GLP-1 drugs like Ozempic and Wegovy.

In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For people who had never been able to lose weight before, suddenly the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. More and more treatment options are becoming available for obesity and overweight. This includes type 2 diabetes drugs and weight loss ...

Zepbound and Ozempic are both prescription drugs part of the GLP-1 agonist drug class. While their uses are different, they do have some similarities, such as dosing schedule and form. This article ...